Alnylam announces results from HELIOS-B Phase 3 study of vutrisiran
PremiumThe FlyAlnylam announces results from HELIOS-B Phase 3 study of vutrisiran
21d ago
Ionis Pharmaceuticals price target raised to $55 from $50 at JPMorgan
Premium
The Fly
Ionis Pharmaceuticals price target raised to $55 from $50 at JPMorgan
25d ago
Alnylam price target raised to $280 from $248 at JPMorgan
Premium
The Fly
Alnylam price target raised to $280 from $248 at JPMorgan
25d ago
Alnylam price target raised to $300 from $265 at Chardan
PremiumThe FlyAlnylam price target raised to $300 from $265 at Chardan
2M ago
Alnylam reports Q2 EPS 56c, consensus ($1.08)
Premium
The Fly
Alnylam reports Q2 EPS 56c, consensus ($1.08)
2M ago
Alnylam Pharmaceuticals (ALNY) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Alnylam Pharmaceuticals (ALNY) Q2 Earnings Cheat Sheet
2M ago
Alnylam price target raised to $288 from $253 at UBS
PremiumThe FlyAlnylam price target raised to $288 from $253 at UBS
3M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
Alnylam price target raised to $265 from $250 at RBC Capital
Premium
The Fly
Alnylam price target raised to $265 from $250 at RBC Capital
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100